ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. C. 医薬保健学域; 医学類・薬学類・医薬科学類・保健学類
  2. c 10. 学術雑誌掲載論文(医・保健)
  3. 1. 査読済論文(医学・保健)

Administration route-dependent induction of antitumor immunity by interferon-alpha gene transfer.

http://hdl.handle.net/2297/48253
http://hdl.handle.net/2297/48253
39cce7b8-5964-4edd-a51b-b02c372cdcdf
名前 / ファイル ライセンス アクション
ME-PR-YAMAGISHI-M-188.pdf ME-PR-YAMAGISHI-M-188.pdf (713.2 kB)
Item type 学術雑誌論文 / Journal Article(1)
公開日 2017-10-03
タイトル
タイトル Administration route-dependent induction of antitumor immunity by interferon-alpha gene transfer.
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
著者 Narumi, Kenta

× Narumi, Kenta

WEKO 25162

Narumi, Kenta

Search repository
Kondoh, Atsushi

× Kondoh, Atsushi

WEKO 25163

Kondoh, Atsushi

Search repository
Udagawa, Takeshi

× Udagawa, Takeshi

WEKO 25164

Udagawa, Takeshi

Search repository
Hara, Hidehiko

× Hara, Hidehiko

WEKO 25165

Hara, Hidehiko

Search repository
Goto, Naoko

× Goto, Naoko

WEKO 25166

Goto, Naoko

Search repository
Ikarashi, Yoshinori

× Ikarashi, Yoshinori

WEKO 25167

Ikarashi, Yoshinori

Search repository
Ohnami, Shumpei

× Ohnami, Shumpei

WEKO 25168

Ohnami, Shumpei

Search repository
Okada, Toshihide

× Okada, Toshihide

WEKO 25169

Okada, Toshihide

Search repository
Yamagishi, Masakazu

× Yamagishi, Masakazu

WEKO 265
e-Rad 70393238
金沢大学研究者情報 70393238
研究者番号 70393238

Yamagishi, Masakazu

Search repository
Yoshida, Teruhiko

× Yoshida, Teruhiko

WEKO 25170

Yoshida, Teruhiko

Search repository
Aoki, Kazunori

× Aoki, Kazunori

WEKO 25171

Aoki, Kazunori

Search repository
書誌情報 Cancer Science

巻 101, 号 7, p. 1686-1694, 発行日 2010-07-01
ISSN
収録物識別子タイプ ISSN
収録物識別子 1347-9032
NCID
収録物識別子タイプ NCID
収録物識別子 AA11808050
DOI
関連タイプ isIdenticalTo
識別子タイプ DOI
関連識別子 10.1111/j.1349-7006.2010.01578.x
出版者
出版者 Japanese Cancer Association = 日本癌学会
抄録
内容記述タイプ Abstract
内容記述 Type I interferon (IFN) protein is a cytokine with pleiotropic biological functions that include induction of apoptosis, inhibition of angiogenesis, and immunomodulation. We have demonstrated that intratumoral injection of an IFN-α-expressing adenovirus effectively induces cell death of cancer cells and elicits a systemic tumor-specific immunity in several animal models. On the other hand, reports demonstrated that an elevation of IFN in the serum following an intramuscular delivery of a vector is able to activate antitumor immunity. In this study, we compared the intratumoral and systemic routes of IFN gene transfer with regard to the effect and safety of the treatment. Intratumoral injection of an IFN-α adenovirus effectively activated tumor-responsive lymphocytes and caused tumor suppression not only in the gene-transduced tumors but also in distant tumors, which was more effective than the intravenous administration of the same vector. The expression of co-stimulatory molecules on CD11c+ cells isolated from regional lymph nodes was enhanced by IFN gene transfer into the tumors. Systemic toxicity such as an elevation of hepatic enzymes was much lower in mice treated by intratumoral gene transfer than in those treated by systemic gene transfer. Our data suggest that the intratumoral route of the IFN vector is superior to intravenous administration, due to the effective induction of antitumor immunity and the lower toxicity. © 2010 Japanese Cancer Association.
権利
権利情報 Copyright © 2010 Japanese Cancer Association
著者版フラグ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
関連URI
識別子タイプ URI
関連識別子 http://www.jca.gr.jp/
関連URI
識別子タイプ URI
関連識別子 http://www.jca.gr.jp/researcher/cancer_science/index.html
戻る
0
views
See details
Views

Versions

Ver.1 2023-07-28 00:47:30.380390
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3